Clinical Trials Browser

Terminated × Colorectal Neoplasms × nintedanib × Clear all

NCT02780700 2025-02-03

Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]

Phase 2 Terminated

1 enrolled 5 charts

Gastrointestinal

Colorectal Neoplasms